Learning Objectives

  1. To discuss the prognostic impact of dic(9;20)(p13.2;q11.2) in pediatric patients with B-ALL through the review of 2 cases. 
  2. To review the somatic mutations identified in a patient with treatment-resistant rhabdomyosarcoma.
  3. To gain education in all aspects of precision medicine, genomics, and advanced therapeutics.
Session date: 
09/05/2019 - 1:00pm to 2:00pm CDT
Location: 
KCBD 1101
900 E 57th Street
Chicago, , IL 60637
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Drs. Lorraine Canham and Tara Suntum